UnitedHealth’s stock can soar 40% as antitrust concerns are overblown, BofA says

Shares of UnitedHealth Group Inc. rallied Thursday after a ringing endorsement from BofA Securities analyst Kevin Fischbeck, who said investor concerns about an antitrust investigation and a recent cyberattack are way overblown.



Source link